DYSLIPIDAEMIA IN 2015: Advances in treatment of dyslipidaemia

    loading  Checking for direct PDF access through Ovid

Abstract

Statins remain the first-line therapy for dyslipidaemia. In 2015, however, effectiveness in reducing serum cholesterol levels and decreasing rates of cardiovascular disease in combination with statins has been demonstrated for two new classes of drugs: cholesterol-absorption inhibitors and PCSK9 inhibitors. The latter rival statins in their capacity to lower cholesterol levels.

Related Topics

    loading  Loading Related Articles